News
03/09/2010 - Holvita™ Liquid Colostrum pilot study
There now exists a respectable body of anecdotal evidence to suggest that the cold-filtered liquid colostrum holvita™ can be of benefit in a number of disorders. A number of chronically ill people with hepatitis c, including those with liver cirrhosis, have claimed a significant improvement in their health and general wellbeing while taking holvita™ liquid colostrum. To determine whether these anecdotal reports are representative a pilot study will begin in the latter part of 2010, involving 20 patients with hepatitis C related liver cirrhosis. Contracts have been signed between CPD Ltd and Barts and the London Hospital NHS Trust to determine the potential value of holvita™ liquid colostrum on patients with hepatitis c related liver cirrhosis. The study will look at the effects of this colostrum on the viral load, the blood picture and quality of life. The Lead Investigator will be Professor Graham Foster, Professor of Hepatology at The Centre for Digestive Diseases, Barts and The London School of Medicine and Dentistry.
We will keep you informed on the ongoing trial, the results will be published once available on our website.
Thank you very much
Kind regards
CPD Ltd. Holvita™ Colostrum team
Price changes - 14/12/08
Due to recent heavy currency fluctuations and the fall in value of Stirling we are forced as of 1st of January 2009 to increase the prices of our liquid and capsule colostrum products. Prices for our skin products will remain unchanged.
Yours sincerely
holvita colostrum team